Will the drug survive on its own?
A medicine must still be the right medicine months or years after it is made. [[solid-state-stability|Solid-state stability]] asks whether the drug, sitting as a powder, slowly changes for the worse. The usual culprits are chemical degradation reactions: hydrolysis (a water molecule splitting the drug, sped up by absorbed moisture), oxidation (reaction with oxygen, often nudged by light or trace metals), and photolysis (breakdown driven by light). Each leaves behind degradation products — impurities that can rob potency or even pose a safety concern.
Preformulation deliberately *stresses* the drug to expose these weaknesses fast: store small samples hot, humid, under bright light, in oxygen, or with traces of acid and base, then measure what survives. The point is not realism but speed — provoke in weeks the failures that might otherwise take years, so the future product can be designed to defend against them.
Will the drug survive its companions?
A tablet is mostly *not* drug. It carries a filler, a binder, a disintegrant, a lubricant, and more. Each excipient is chosen to help — but some quietly attack the drug. [[drug-excipient-compatibility|Drug–excipient compatibility]] testing checks, before any recipe is fixed, whether the drug and each helper can live together. A classic offender is the lubricant magnesium stearate, which is alkaline and can degrade acid-sensitive drugs; reducing sugars can react with amine drugs; and many excipients carry just enough moisture to trigger hydrolysis.
- Make binary blends — drug mixed with each candidate excipient, usually with a little added water to amplify any reaction.
- Stress and store the blends warm and humid alongside drug-only and excipient-only controls.
- Look for trouble — new impurities by assay, colour change, or shifted/lost peaks by DSC hinting at interaction or melting.
- Shortlist the friendly excipients and quietly drop the troublemakers before formulation begins in earnest.
A first estimate of shelf life
Stress testing also lets us *estimate* how long a drug will last. Most degradation speeds up with temperature in a predictable way described by the [[phc-arrhenius-equation|Arrhenius equation]]. The strategy behind accelerated stability testing is to measure degradation rate constants at several high temperatures, then extrapolate down to room temperature to predict the shelf life. A handy shortcut is the Q10 factor — a rule of thumb that reaction rate roughly doubles to triples for every 10 °C rise.
Arrhenius shelf-life estimate (worked sketch)
Arrhenius: k = A * exp(-Ea / (R * T)) => ln k = ln A - Ea/(R*T)
Measured first-order degradation rate constants:
50 C (323 K): k = 8.0e-3 per month
40 C (313 K): k = 2.5e-3 per month
Solve for activation energy Ea (R = 8.314 J/mol/K):
ln(8.0e-3 / 2.5e-3) = (Ea/R) * (1/313 - 1/323)
ln(3.2) = 1.163 = (Ea/8.314) * (9.89e-5)
Ea = 1.163 * 8.314 / 9.89e-5 ≈ 97,800 J/mol (~98 kJ/mol)
Extrapolate to 25 C (298 K):
ln k(298) = ln(2.5e-3) - (Ea/R)*(1/298 - 1/313)
= -5.99 - (11763)*(1.608e-4) = -5.99 - 1.89 = -7.88
k(298) = 3.8e-4 per month
Shelf life to 10% loss (first order): t90 = 0.105 / k
t90 = 0.105 / 3.8e-4 ≈ 276 months ≈ 23 years (drug alone, idealized)
Note: a real product with excipients and moisture will be far less stable;
this is an order-of-magnitude preformulation estimate, not a label claim.